Viewing StudyNCT00072579



Ignite Creation Date: 2024-05-05 @ 11:31 AM
Last Modification Date: 2024-10-26 @ 9:09 AM
Study NCT ID: NCT00072579
Status: COMPLETED
Last Update Posted: 2017-01-19
First Post: 2003-11-04

Brief Title: Sargramostim in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia Who Are Not in Complete Cytogenetic Remission Following Initial Treatment
Sponsor: Wake Forest University Health Sciences
Organization: Wake Forest University Health Sciences

Conditions & Keywords Data

Conditions:
Name
Leukemia
Keywords:
Name View
chronic myelogenous leukemia BCR-ABL1 positive View
chronic phase chronic myelogenous leukemia View